Life Sciences thought leadership series

The biomedicine revolution

With this journal, we wanted to illuminate some current manufacturing challenges, breakthrough technologies, and the changing regulatory landscape in the production of biomedicines. 

Enter cell and gene therapies, personalized medicines and new biomolecular technologies. Changing business models require consideration for smaller,
more precise and agile production methods. The future is here, it is advancing exponentially, and it is both filled with hope and trepidation.

Automation is everywhere. The pharmaceutical industry—at all scales of development and production—stands to benefit from more efficient production, using the right systems, which should ultimately be reflected in lower priced, more accessible and appropriate medicines.